In summary, our findings show that treatment of tumour‐bearing mice with TNFα targeted to tumour laminin–nidogen complexes is well tolerated and induces tumour infiltration of immune cells, which in turn results in loss of tumour ECM, improved tumour perfusion, reduced tumour burden and enhanced overall survival. This evidence concerns the gene TNF and neoplasm.